Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion type Assertion NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_head.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion description "[Bioassay studies indicate that these low levels of soluble CD95 in the CSF of some patients with malignant glioma cells are unlikely to interfere with CD95-based immunotherapy of malignant gliomas in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_provenance.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion evidence source_evidence_literature NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_provenance.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion SIO_000772 10066095 NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_provenance.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion wasDerivedFrom befree-20140225 NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_provenance.
- NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_assertion wasGeneratedBy ECO_0000203 NP715730.RAWIy9RqIqq442gswX_KBbvj1lH0qEdQipqJ7SGjLfP4c130_provenance.